Alignment Healthcare, Inc.

As of September 2, 2025, Alignment Healthcare, Inc. shows a mildly bullish trend with strong multi-period returns and several bullish indicators, despite some bearish signals in daily moving averages.

As of October 5, 2023, Alignment Healthcare, Inc. is considered attractive and undervalued with a P/E ratio of 18.5 and a P/S ratio of 1.2, trading at a discount compared to peers like Centene and Molina Healthcare, while also outperforming the Sensex.

As of October 1, 2023, there is insufficient technical data for Alignment Healthcare, Inc. to determine a bullish or bearish outlook.

Alignment Healthcare, Inc. is a micro-cap company in the healthcare services industry, reporting a net loss of $9 million as of March 2025, with a market cap of approximately $2.88 billion. Key metrics include a negative P/E ratio, no dividend yield, and a return on equity of -81.23%.

As of Jun 18, Alignment Healthcare, Inc. has a market capitalization of $2.88 billion, with reported net sales of $0 million and a net profit of -$90.84 million over the last four quarters. Shareholder's funds were $99.85 million, and total assets amounted to $782.06 million.